|
|
||||||||
Ann Thorac Surg 2005;80:179-182
© 2005 The Society of Thoracic Surgeons
Albert Einstein Medical Center, Jefferson Health System, Philadelphia, Pennsylvania
Accepted for publication January 7, 2005.
* Address reprint requests to Dr Quigley, Division of Cardiothoracic Surgery, Albert Einstein Medical Center-Jefferson Health System, 5501 Old York Rd, Levy 3 East, Philadelphia, PA19141 (Email: quigleyr{at}einstein.edu).
Presented at the Fifty-first Annual Meeting of the Southern Thoracic Surgical Association, Cancun, Mexico, Nov 24, 2004.
| Abstract |
|---|
|
|
|---|
METHODS: Between January 1, 1996 and January 6, 2003, we performed elliptical excisions of the base of the anterior leaflet in 47 patients with a mean age of 66 years (range, 29 to 86). All patients had an anterior leaflet height of 3.0 cm or more and an annular diameter of 4.0 cm or more. Repairs included posterior leaflet (37; 80%), and anterior leaflet (28; 61%) resections, with occasional transposition flaps (9; 19%). All 47 (100%) had an annuloplasty ring (9, Physio; 37, Seguin). Four (8%) included tricuspid repair, 6 (13%) aortic valve replacement, and 9 (19%) coronary artery bypass. Follow-up was between 2 months and 8 years.
RESULTS: There was no systolic anterior motion or in-hospital (30-day) mortality. Postoperative echocardiography revealed an average anterior leaflet height of 2.2 ± 0.3 cm, with an annular diameter of 3 ± 0.2 cm. The anterior/posterior leaflet ratio decreased from 1.6 ± 0.2 to 1.4 ± 0.1 cm while the coaptation pointannular plane distance decreased from 1.2 ± 0.2 to 0.9 ± 0.1 cm. There were 4 late noncardiac deaths. Two patients have required mitral valve replacement owing to progressive disease and 6 patients were lost to follow-up. The 35 patients remaining have trace-mild mitral regurgitation.
CONCLUSIONS: Our anterior mitral valve leaflet valvuloplasty, regardless of the ring, results in a decrease in surface area and excursion of the anterior leaflet without systolic anterior motion.
| Introduction |
|---|
|
|
|---|
Grossi and colleagues [5] were the first to challenge this theory and proposed triangular resection of the AMVL to reduce the incidence of SAM in this context. The hypothesis of a large redundant AMVL as the primary etiology of SAM has more recently been supported by Shah and Raney [6], who recommend reduction of the AMVL height to prevent SAM.
As early as 1995, we recognized the significance of the AMVL in postrepair SAM in 3 patients with severely myxomatous valves, and subsequently defined a simple AMVL valvuloplasty to reduce AMVL height and eliminate postrepair SAM precluding mitral valve replacement [7]. Using previously described echocardiographic morphologic determinants of SAM, in this report, we objectively evaluate the efficacy of this procedure in a cohort of patients with complex floppy mitral valves [1].
| Patients and Methods |
|---|
|
|
|---|
|
|
|
Echocardiography
The mitral valve was assessed both preoperatively and postoperatively using transesophageal echocardiography from the transverse five-chamber views, as described by Lee and coworkers [9], at the end of diastole. The preoperative and postoperative severity of mitral regurgitation was quantified, and the postoperative presence of SAM evaluated [10]. Preoperatively, the anatomic defect responsible for the mitral regurgitation was identified with multiplane transesophageal echocardiography, as were the dimensions of the subvalvular apparatus (AMVL, PMVL, and CPAD [the distance between the leaflet coaptation point and the annular plane]). The leaflets were measured in the coaptive position (annulus to coaptation edge). After implantation of the ring, the annular diameter was made from the inner aspects of this prosthesis.
Results
All 47 patients were successfully weaned from cardiopulmonary bypass with trace or mild mitral regurgitation and no SAM. Table 2 compares the preoperative and postoperative echocardiographic morphologic variables that were quantified. There were no perioperative myocardial infarctions or deaths within 30 days. The mean cardiopulmonary bypass time was 91 ± 26 minutes with a mean cross-clamp time of 76 ± 14 minutes. There were no clinically significant gradients across the mitral valve after the repair. All patients were followed up annually with echocardiography, and to date, only 2 have required reoperation for symptomatic recurrent mitral regurgitation. Six patients were lost to follow-up, however, and 4 have died from unrelated medical conditions.
|
| Comment |
|---|
|
|
|---|
2.7 cm), elongated PMVL (
1.5 cm), and annular dilatation (
3.2 cm). Those 3 affected patients diagnosed with SAM intraoperatively after repair, and who were refractory to fluid challenges or inotrope withdrawal, underwent revision of their MVR with an elliptical AMVL valvuloplasty. In all such cases, intraoperative transesophageal echocardiography not only revealed resolution of SAM, but also of the associated mitral regurgitation. There were no cases of SAM diagnosed postoperatively after exit from the operating room. In this study, 47 patients with the described mitral valve characteristics prospectively had this AMVL valvuloplasty in addition to their repair, and none experienced SAM postoperatively. Coincidentally, none of the other 249 MVR cases performed during this same period experienced postrepair SAM. Although there is some controversy in the literature as to the exact mechanism of SAM and LVOTO after MVR, most authors concur that a postoperative increase in the CPAD increases the likelihood of this complication [1, 2]. As indicated in this report, this increase in the CPAD is related predominately to AMVL length [5, 6, 11] and to a lesser extent to PMVL [9, 12].
Mihaileanu and colleagues [4] have suggested that the etiology of LVOTO after MVR is multifactorial and may include narrowing of the mitroaortic angle. It is interesting that some of our patients who experienced LVOTO after MVR, before this study, did have a dilated cardiomyopathy and by definition widened mitroaortic angles. The LVOTO observed in these cases was after a significant reduction annuloplasty. This observation justified our prophylactic AMVL elliptical valvuloplasty, even in those patients with depressed left ventricle function and coincidental left ventricular dilatation.
The results of this study suggest that transesophageal echocardiography analysis of the mitral valve apparatus can identify patients who have a severely myxomatous mitral valve, likely to develop SAM/LVOTO after MVR. Furthermore, a simple elliptical excision at the base of the AMVL, at least in this series, not only eliminated the need for the time-consuming and sometimes complicated sliding posterior leaflet procedure previously thought to be indicated in this clinical scenario, but also avoided mitral valve replacement. Finally, this technique eliminates SAM without compromising flow across the mitral valve apparatus, which can occur with the Alfieri stitch recently proposed for the same purpose [13].
| Discussion |
|---|
|
|
|---|
In our practice, we basically dont see SAM at all. So I am interested in knowing is there something else that is missing there to produce this higher incidence of SAM that would make you develop a new technique to avoid it?
DR QUIGLEY: Your point is well taken. I want to emphasize that the historic or traditional thinking has been that the etiology of SAM, particularly in this subset of patients with severely myxomatous floppy mitral valves, is a high-riding posterior leaflet. In my primitive mind, I kept having difficulty with that concept, even though I was reprimanded by Professor Carpentier when I challenged his theory, because it was his original theory. I kept thinking that it is the anterior leaflet that actually obstructs the outflow tract, and so if I could somehow modify the surface area and the excursion of the anterior leaflet, I could then avoid doing the sliding plasty, which I used to do in my earlier career.
I found, as I mentioned at the beginning of the talk, that it was somewhat laborious, and in that particular subset of patients, we werent getting a hundred percent prevention of SAM. Even one case of SAM can be devastating, and that was the reason why this particular procedure was undertaken and then prospectively evaluated over an 8-year period.
DR JOHN H. CALHOON (San Antonio, TX): I enjoyed your presentation. I probably didnt fully understand it. It was pretty complex. My question is how often did you see SAM in this group, or did you just adopt this technique so that you would no longer see SAM? What was your percentage of SAM before you did this, for instance?
DR QUIGLEY: Our incidence of SAM in that population of patients, and we were seeing a lot of that population of patients in the mid to late 1990s, was less than 10%; it was somewhere between 6% and 8%. In the presentation I included one of the original cases on video. It was the original preoperative video, then in the immediate postrepair video there was SAM, and then that same case, after we had left the ring intact and done our elliptical excision the SAM and outflow tract obstruction resolved along with the associated mitral regurgitation. After having several of these patients, it was then we decided to proactively go ahead and do this procedure on all of the patients who met those criteria that I previously discussed.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P.M. McCarthy, E.C. McGee, V.H. Rigolin, Q. Zhao, H. Subacius, A.L. Huskin, S. Underwood, B.J. Kane, I. Mikati, G. Gang, et al. Initial clinical experience with Myxo-ETlogix mitral valve repair ring J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow Evolving Concepts and Technologies in Mitral Valve Repair Circulation, February 19, 2008; 117(7): 963 - 974. [Full Text] [PDF] |
||||
![]() |
M. L. Brown, M. D. Abel, R. L. Click, R. G. Morford, J. A. Dearani, T. M. Sundt, T. A. Orszulak, and H. V. Schaff Systolic anterior motion after mitral valve repair: Is surgical intervention necessary? J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Adams, A. C. Anyanwu, P. B. Rahmanian, V. Abascal, S. P. Salzberg, and F. Filsoufi Large Annuloplasty Rings Facilitate Mitral Valve Repair in Barlow's Disease Ann. Thorac. Surg., December 1, 2006; 82(6): 2096 - 2101. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |